Filana Therapeutics (FLNA)

• Market cap: $75.4M
• 1 day: -3.11%
• 5 days: -10.86%
• 1 month: -6.59%
• 3 months: -26.42%
• 6 months: -58.95%
• Year to date: -25.36%
• 1 year: -1.89%
• 5 years: -96.48%
• 10 years: -91.23%
• Sector: Healthcare
• Industry: Biotechnology

About: Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Employees: 20